Ironwood Pharmaceuticals, Inc.
IRWD
$1.55
-$0.06-3.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 163.12% | -1,757.18% | -38.12% | 523.95% | 79.34% |
| Total Depreciation and Amortization | -2.51% | -1.24% | -46.53% | 79.25% | -1.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 188.06% | -85.28% | 188.66% | -29.97% | 47.70% |
| Change in Net Operating Assets | -217.19% | 248.98% | -216.11% | -196.47% | -66.80% |
| Cash from Operations | -175.51% | 31.16% | 53.91% | -70.46% | -25.61% |
| Capital Expenditure | 93.55% | -- | 100.00% | 72.41% | 14.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.55% | -- | 100.00% | 72.41% | 14.71% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | 40.00% | 87.50% | -700.00% |
| Issuance of Common Stock | 1,366.67% | -97.04% | -- | -100.00% | -92.56% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 80.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 95.83% | -- | -- |
| Cash from Financing | 1,366.67% | 100.04% | 45.18% | 45.00% | -217.40% |
| Foreign Exchange rate Adjustments | -9,142.86% | -133.33% | 180.77% | 49.02% | -312.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -178.45% | 5,624.71% | 102.01% | -8.10% | -154.50% |